Skip to main content
. 2022 Oct 21;51(5):386–395. doi: 10.1159/000526863

Fig. 3.

Fig. 3

Comparison of anticholinergic burdens of PD-MCI and PD-NC groups. ACB, Anticholinergic Cognitive Burden scale; ADS, Anticholinergic Drug Scale; ARS, Anticholinergic Risk Scale; PD-MCI, Parkinson's disease-mild cognitive impairment; PD-NC, Parkinson's disease-normal cognition.